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tential similarities with that of spirochetes, is likely to
differ from the known swimming mechanisms of other
helical organisms.
Could a rotary mechanism such as that seen in spiro-
chetes be at play during Spiroplasma movement? Initial
evidence suggested that deformation of the cytoskele-
tal ribbon produces traveling kinks in the cell body of
Spiroplasma that induce movement (Trachtenberg,
2004). In their new work, Shaevitz et al. (2005) show
that kinking in Spiroplasma is actually composed of
two temporally distinct types of cell deformation. The
first deformation flips the handedness of the cell helix
(a right-handed helix becomes left-handed) at one end
of the cell body. The deformation grows in the direction
of the opposite end of the cell. After an average of
0.26 s, the initiating end of the cell, in a second defor-
mation, flips back to its original handedness and cre-
ates a packet of opposite handedness that travels the
length of the cell to the distal end. Propagation of these
double kinks produces motility in the direction of the
cell body helix axis and also rotation of the cell body
around the helix axis.
This type of movement behavior in Spiroplasma can
best be explained by the presence of an internal con-
tractile apparatus (Kurner et al., 2005; Trachtenberg,
2004; Wolgemuth et al., 2003). A mathematical model
describes how periodic changes in helix pitch can pro-
duce propulsive force (Wolgemuth et al., 2003). This
mathematical model predicts that deformations driven
by contractions would lead to swimming velocities that
increase with increasing fluid viscosity, if kink velocity
is independent of the viscosity. Confirming this predic-
tion, Shaevitz et al. (2005) show that the kink velocity is
indeed independent of viscosity. It should be men-
tioned that no contractile apparatus has yet been defin-
itively shown for any bacterial motility apparatus (al-
though the bacterial tubulin-like protein, FtsZ, does
form a contractile ring during cell division [Bi and Lut-
kenhaus, 1991]). Also, no genes encoding eukaryotic
contractile proteins have been detected in the Spiro-
plasma genome.
Although Spiroplasma movement mediated by an in-
ternal contractile apparatus is the favored explanation,
another possibility that cannot be ruled out is the pres-
ence of a rotating internal filament. A rotation model
would require that the helical ribbons be polymorphic
like bacterial flagella, which change handedness upon
reversal of the flagellar motor. Torque placed on the rib-
bons could flip the handedness of the cell shape
thereby causing kinks.
Many questions remain to be answered. For instance,
observations of Spiroplasma do not suggest that this
bacterium has polarity: one end of the cell appears no
different than the other. Yet, the results presented by
Shaevitz et al. (2005) suggest that the same end of the
cell always initiates the kinks. This result may have
bearing on the motility of many other bacterial species.
For example, it remains unclear how spirochetes can
simultaneously regulate their flagellar motors at both
ends of the cell during chemotaxis. Polarity of the cell
may provide an easy answer. However, the most intrigu-
ing questions relate to how the kinks are generated.
The answers to these questions will likely come from
the establishment of a system that allows kinks to be
studied in vitro. We excitedly await this development.
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Chipping away at the Embryonic
Stem Cell Network
Critical transcription factors, notably OCT4, SOX2, and
NANOG, are necessary to maintain self-renewal and
pluripotency, two properties characteristic of embry-
onic stem (ES) cells. By analyzing the genome-wide
localization of these factors at promoter regions in
human ES cells, Boyer et al. (2005) demonstrate fre-
quent promoter cooccupancy at numerous target
genes. As they discuss in this issue of Cell, their find-
ings indicate the presence of a complex network of
autoregulatory and feedforward loops in human ES
cells.
Embryonic stem (ES) cells, grown from the inner cell
mass of early blastocysts, are remarkable cells. They
display the two defining properties of true stem cells,
that is, self-renewal and pluripotency. Propagated un-
Previews
829der appropriate conditions, ES cells continue to pro-
duce more stem cells (the process of self-renewal).
Simultaneously, they retain the capacity to generate all
types of differentiated progeny, either in vitro or in vivo
(the phenomenon of pluripotency). As such, ES cells of
human origin (hES cells) are envisioned as an excellent
source for cellular approaches to the therapy of various
diseases, which is the emerging area of regenerative
medicine (Pera and Trounson, 2004).
For all of their promise, hES cells are not without con-
troversy. Their derivation from early human embryos
presents ethical issues for many that trump any poten-
tial health benefits. If we could coax somatic cells to
become “ES cell like” by manipulations in the labora-
tory, cells for regenerative medicine might be obtained
without the destruction of embryos. Seen in this con-
text, understanding how the ES cell state is established
and maintained is fundamental to intelligent and ac-
ceptable use of hES cells in the future.
In practice, deconstructing the ES cell phenotype
can be reduced to elucidating the transcriptional cir-
cuitry that controls self-renewal and pluripotency. If a
few key transcription factors dominate, one might envi-
sion introducing these in a controlled fashion into so-
matic cells or activating expression of their resident
genes to elicit an ES cell fate. If a larger number of
factors are involved, a similar conversion might require
a series of successive, directed steps. The recent dem-
onstration that the ES cell phenotype is dominant to
somatic cell fate in cell hybrids provides evidence that
the cellular components that maintain ES cell proper-
ties override more differentiated phenotypes (Cowan et
al., 2005).
Currently, the repertoire of transcription factors re-
quired for ES cell identity is deceptively small (Cham-
bers, 2004). Indeed, two variant homeodomain pro-
teins, OCT4 and NANOG, are principal players, along
with an HMG factor, SOX2, that acts with OCT4 at spe-
cific promoter elements. Boyer et al. (2005) in this issue
of Cell provide a first glimpse into the complexity of
gene targets regulated by these factors in hES cells.
They couple chromatin immunoprecipitation (ChIP) with
DNA microarrays (Chips), the so-called ChIP-Chip
analysis (Horak and Snyder, 2002), to identify DNA
bound individually by OCT4, NANOG, and SOX2. Their
major experimental finding is that these factors co-Figure 1. Regulatory Circuitry in ES Cells
The core transcription factors, NANOG,
SOX2, and OCT4, activate target genes in ES
cells that encode signaling components and
other pluripotency/self-renewal factors. They
also repress the expression of genes encod-
ing components of pathways that promote
ES cell differentiation. Pluripotency/self-
renewal factors “downstream” of the core
factors are also likely to contribute to repres-
sion of genes that induce ES cell differentia-
tion, thereby reinforcing the off state. The
core factors and downstream pluripotency/
self-renewal genes are involved in auto- and
crossregulatory loops. It is likely that down-
stream pluripotency/self-renewal factors con-
tribute to transcriptional control of the core
factors.occupy the promoters of many genes in hES cells, im-
plicating an intertwined network in the control of ES cell
fate by a relatively small number of transcription
factors.
Boyer et al. (2005) use state-of-the-art ChIP-Chip meth-
odology in their study. Although the DNA microarrays
encompass only the −8 kb to +2 kb region (relative to
the transcript start sites) and transcriptional control
may take place over far greater distances in vivo, they
provide evidence that the vast majority of detected
binding sites occur within this interval. As the Chips
assay includes promoters of nearly 18,000 human
genes, their analysis is truly genome-scale in scope
and will provide much fodder for subsequent analysis.
An immediate surprise is the high number of promoter
regions bound by the three transcription factors tested.
NANOG occupied 9% of the promoter regions, SOX2
7%, and OCT4 3%. Taken at face value, these data
point to a pervasive contribution of these transcription
factors to the cellular phenotype, rather than a model
in which each regulates a very limited number of target
genes in a cascade. The proportion of genes bound by
these factors approximates that observed previously
for dominant lineage-specific differentiation factors,
such as the hepatocyte nuclear factors, in pancreatic
and liver cells (Odom et al., 2004). The most provoca-
tive finding in this work is the frequent co-occupancy
of the gene promoters bound by OCT4, NANOG, and
SOX2. Indeed, 353 genes were bound by all three tran-
scription factors. At least as many (492) genes were
bound by SOX2 and NANOG, whereas a smaller num-
ber (80 genes) were bound by OCT4 and NANOG. In-
deed, the vast majority of genes bound by OCT4 and
SOX2 were also bound by NANOG. The inescapable
conclusion is that these three factors work together,
rather than separately, to control whole sets of target
genes in ES cells.
In a second level of analysis, Boyer et al. (2005) show
that roughly half of the genes bound by OCT4, NANOG,
and SOX2 are expressed in ES cells. Among these are
the promoters of the genes themselves, as well as com-
ponents of signaling pathways such as the TGF-β and
Wnt pathways that have been implicated in ES cell self-
renewal. On the other hand, genes whose promoters
are co-occupied by OCT4, NANOG, and SOX2 and are
not expressed include many transcription factors be-
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830lieved to be critical for germ-layer-specific differentia-
tion. Furthermore, they note that among this class, ho-
meodomain proteins appear to be enriched. Though
the in silico analysis does not reveal whether protein
occupancy translates into control of the individual
targets identified, experimental evidence from other
studies indicates that OCT4 and SOX2 bind to and
function at the OCT4 and NANOG gene promoters in
more conventional assays (Kuroda et al., 2005; Oku-
mura-Nakanishi et al., 2005). On the other hand, it
should be kept in mind that protein occupancy is not
necessarily a predictor of action at a presumptive tar-
get gene (Zhang et al., 2005). Nonetheless, despite the
adage that transcription factor binding is not necessar-
ily equal to activity, it is probable that Boyer and col-
leagues (2005) have identified many of the biologically
relevant targets of OCT4, SOX2, and NANOG. Refined
experimental approaches are required to sift through
the candidates to assess whether gene activation or
repression is truly dependent on these factors.
Two simple regulatory network motifs are proposed
to account for the new data. A feedforward loop sug-
gests that OCT4 and SOX2 converge on the regulation
of NANOG, which, in turn, acts with these proteins to
control a vast array of downstream targets. This ar-
rangement allows for both stability and developmental
switching, depending on the activities and concentra-
tions of the individual factors themselves, and also sug-
gests that NANOG maintains a pivotal position in the
regulatory hierarchy. Consistent with the co-occupancy
of their promoters by the factors themselves, Boyer et
al. (2005) propose that OCT4, SOX2, and NANOG con-
form to an autoregulatory loop, which serves again to
maintain options of both stability and switching. In the
differentiation of tissue-specific lineages, regulatory
factors often operate in both positive and negative
fashions to refine the ultimate developmental decision
(Orkin, 2000). Here, too, it appears that the central fac-
tors OCT4, SOX2, and NANOG are likely to promote
expression of other pluripotency/self-renewal genes as
well as themselves, while simultaneously preventing
expression of differentiation-promoting genes. Their
actions are reinforced by the inhibitory effects of their
target pluripotency genes on differentiation (see Fig-
ure 1).
The elegant study of Boyer et al. (2005) is an initial
step in deciphering the network of transcription factors
that regulate ES cells. However, many important ques-
tions remain unanswered. Given the intricate network
apparent from the consideration of just three compo-
nents, we must ask how many other key pluripotency
factors with properties overlapping those of OCT4,
SOX2, and NANOG remain to be identified. If, as seems
likely, OCT4, SOX2, and NANOG can have either posi-
tive or negative effects on their target genes, how do
extracellular signals or other regulatory factors control
their transcriptional activities? Do cofactors for these
transcription factors further integrate aspects of the
regulatory network? What distinguishes those targets
that might be acted upon by one of these key regula-
tors (such as NANOG) in the absence of the others?
Looking ahead, the success of network dissection may
be judged by how well the insights gained allow manip-































Dre just at the beginning of this journey. Given the com-
lexity of the preliminary roadmap there are likely to be
any detours along the way.
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